Market Overview

UPDATE: ISI Group Initiates Market Weight, $45 PT on Illumina on Soft Demand Environment

Share:
Related ILMN
Benzinga's Top Initiations
Burning Rock, Illumina Announce Collaboration on Molecular Diagnostics for Oncology
Illumina Acquires GenoLogics, Boosts Genomic Sequencing (Zacks)

ISI Group initiated its coverage on Illumina (NASDAQ: ILMN) with a Market Weight rating and a $45 price target.

ISI Group noted, "We are initiating coverage on shares of Illumina with a Market Weight rating and a price target of $45.00, which on a forward basis equates to ~12x EV/EBITDA and ~25x operating EPS. Our thesis for ILMN is based on our view that strong growth in MiSeq and an improving HiSeq through-put will help to offset an increasingly challenging budgetary environment, that microarray growth will remain modest as demand for emerging applications helps to soften a slowdown in legacy GWAS, and that recent strategic interest in asset (e.g. Roche's hostile bid) provides a modest valuation premium."

Illumina closed at $40.60 on Monday.

Latest Ratings for ILMN

DateFirmActionFromTo
Aug 2015Cantor FitzgeraldInitiates Coverage onBuy
Aug 2015Mizuho SecuritiesReinstatesBuy
Jul 2015Janney CapitalDowngradesBuyNeutral

View More Analyst Ratings for ILMN
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Price Target Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (ILMN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters